Neuroone Medical Technologies (NMTC) Return on Sales (2010 - 2026)

Neuroone Medical Technologies' Return on Sales history runs 13 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, up 3.0% from the prior year.
• Return on Sales was 0.01% for Q1 2026 at Neuroone Medical Technologies, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2024 and bottomed at 0.86% in Q2 2022.
• A 5-year average of 0.15% and a median of 0.03% in 2023 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 217 bps in 2022, while the deepest fall reached 12 bps in 2022.
• Neuroone Medical Technologies' Return on Sales stood at 0.15% in 2022, then jumped by 77 bps to 0.03% in 2023, then soared by 116 bps to 0.01% in 2024, then plunged by 191 bps to 0.0% in 2025, then slumped by 157 bps to 0.01% in 2026.
• Business Quant data shows NMTC's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.